These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34607401)

  • 41. Effective COVID-19 Control: A Comparative Analysis of the Stringency and Timeliness of Government Responses in Asia.
    Chen S; Guo L; Alghaith T; Dong D; Alluhidan M; Hamza MM; Herbst CH; Zhang X; Tagtag GCA; Zhang Y; Alazemi N; Saber R; Alsukait R; Tang S
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful control of COVID-19 outbreak through tracing, testing, and isolation: Lessons learned from the outbreak control efforts made in a metropolitan city of South Korea.
    Kang SJ; Kim S; Park KH; Jung SI; Shin MH; Kweon SS; Park H; Choi SW; Lee E; Ryu SY
    J Infect Public Health; 2021 Sep; 14(9):1151-1154. PubMed ID: 34364306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 in Asia: Transmission factors, re-opening policies, and vaccination simulation.
    Baniasad M; Mofrad MG; Bahmanabadi B; Jamshidi S
    Environ Res; 2021 Nov; 202():111657. PubMed ID: 34246638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elimination, Containment, and Mitigation of COVID-19: A Personal Story about International Travels.
    Hon KL; Leung KKY
    Curr Pediatr Rev; 2023; 19(3):218-222. PubMed ID: 36017828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
    Brett TS; Rohani P
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25897-25903. PubMed ID: 32963094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Debate on Public Health Responses to COVID-19: Focused Protection versus Sustained Suppression.
    Song JY; Peck KR;
    J Korean Med Sci; 2020 Dec; 35(49):e433. PubMed ID: 33350189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal Social Distancing Policy for COVID-19 Control in Korea: A Model-Based Analysis.
    Jo Y; Shrestha S; Radnaabaatar M; Park H; Jung J
    J Korean Med Sci; 2022 Jun; 37(23):e189. PubMed ID: 35698839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 Epidemic in Malaysia: Epidemic Progression, Challenges, and Response.
    Hashim JH; Adman MA; Hashim Z; Mohd Radi MF; Kwan SC
    Front Public Health; 2021; 9():560592. PubMed ID: 34026696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the reproductive number and the outbreak size of COVID-19 in Korea.
    Choi S; Ki M
    Epidemiol Health; 2020; 42():e2020011. PubMed ID: 32164053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.
    Gomes MGM; Ferreira MU; Corder RM; King JG; Souto-Maior C; Penha-Gonçalves C; Gonçalves G; Chikina M; Pegden W; Aguas R
    J Theor Biol; 2022 May; 540():111063. PubMed ID: 35189135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
    Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of physical distancing policy on reducing transmission of SARS-CoV-2 globally: Perspective from government's response and residents' compliance.
    Chung PC; Chan TC
    PLoS One; 2021; 16(8):e0255873. PubMed ID: 34375342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 herd immunity by immunisation: are children in the herd?
    Obaro S
    Lancet Infect Dis; 2021 Jun; 21(6):758-759. PubMed ID: 33887207
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
    Daher-Nashif S; Al-Anany R; Ali M; Erradi K; Farag E; Abdallah AM; Emara MM
    Arch Virol; 2022 Sep; 167(9):1773-1783. PubMed ID: 35723757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 40 health systems, COVID-19 (40HS, C-19) study.
    Braithwaite J; Tran Y; Ellis LA; Westbrook J
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 32991713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percentages of Vaccination Coverage Required to Establish Herd Immunity against SARS-CoV-2.
    Plans-Rubió P
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The detection of the epidemic phase of COVID-19 and the timing of social distancing policies in Korea.
    Kim W
    Public Health; 2021 Dec; 201():89-97. PubMed ID: 34798328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.